L-MTP-PE
Term · Oncology and biomedicine · MLC-T-ONC-004892
A drug being studied in the treatment of young adults with bone cancer that has gotten worse or come back. L-MTP-PE activates certain types of white blood cells and helps the immune system kill cancer cells. It is a type of immunostimulant. Also called MEPACT, mifamurtide, and muramyl tripeptide phosphatidylethanolamine.
| Identifier | MLC-T-ONC-004892 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | mifamurtide; muramyl tripeptide phosphatidylethanolamine |
| Synonyms | MEPACT |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-004892",
"term": "L-MTP-PE",
"field": "Oncology and biomedicine",
"definition": "A drug being studied in the treatment of young adults with bone cancer that has gotten worse or come back. L-MTP-PE activates certain types of white blood cells and helps the immune system kill cancer cells. It is a type of immunostimulant. Also called MEPACT, mifamurtide, and muramyl tripeptide phosphatidylethanolamine.",
"expansions": [
"mifamurtide",
"muramyl tripeptide phosphatidylethanolamine"
],
"synonyms": [
"MEPACT"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/l-mtp-pe/"
}
Record 10,256 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.